Literature DB >> 14703511

Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation.

Helen H Wang1, Nezam H Afdhal, Sandra J Gendler, David Q-H Wang.   

Abstract

Gallbladder mucins play a critical role in the pathogenesis of cholesterol gallstones because of their ability to bind biliary lipids and accelerate cholesterol crystallization. Mucin secretion and accumulation in the gallbladder is determined by multiple mucin genes. To study whether mucin gene 1 (Muc1) influences susceptibility to cholesterol cholelithiasis, we investigated male Muc1-deficient (Muc1(-/-)) and wild-type mice fed a lithogenic diet containing 1% cholesterol and 0.5% cholic acid for 56 days. Gene expression of the gallbladder Muc1 and Muc5ac was significantly reduced in Muc1(-/-) mice in response to the lithogenic diet. Muc3 and Muc4 levels were upregulated and were similar between Muc1(-/-) and wild-type mice. Little or no Muc2 and Muc5b mRNAs were detected. Muc1(-/-) mice displayed significant decreases in total mucin secretion and accumulation in the gallbladder as well as retardation of crystallization, growth, and agglomeration of cholesterol monohydrate crystals. At 56 days of feeding, gallstone prevalence was decreased by 40% in Muc1(-/-) mice. However, cholesterol saturation indices of gallbladder bile, hepatic secretion of biliary lipids, and gallbladder size were comparable in Muc1(-/-) and wild-type mice. We conclude that decreased gallstone formation in mice with disrupted Muc1 gene results from reduced mucin secretion and accumulation in the gallbladder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14703511     DOI: 10.1194/jlr.M300468-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  12 in total

1.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

Review 2.  Genetically engineered mucin mouse models for inflammation and cancer.

Authors:  Suhasini Joshi; Sushil Kumar; Sangeeta Bafna; Satyanarayana Rachagani; Kay-Uwe Wagner; Maneesh Jain; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

3.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

Review 4.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

5.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.

Authors:  Laetitia Finzi; Véronique Barbu; Pierre-Regis Burgel; Martine Mergey; Kimberly S Kirkwood; Elizabeth C Wick; Jean-Yves Scoazec; Frédérique Peschaud; François Paye; Jay A Nadel; Chantal Housset
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 6.  Cholesterol gallstone disease: focusing on the role of gallbladder.

Authors:  Yongsheng Chen; Jing Kong; Shuodong Wu
Journal:  Lab Invest       Date:  2014-12-15       Impact factor: 5.662

7.  The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice.

Authors:  Laura E Johnson; Marc S Elias; David T Bolick; Marcus D Skaflen; Richard M Green; Catherine C Hedrick
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

8.  Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.

Authors:  Tze Wei Poh; Judy M Bradley; Pinku Mukherjee; Sandra J Gendler
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiography.

Authors:  Alexander Vilkin; Alex Geller; Zohar Levi; Yaron Niv
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 10.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.